Health - Google News: FDA Approves Pfizer's Bosulif For Patients With Previously Treated Ph+ CML - RTT News

Health - Google News Google News

FDA Approves Pfizer's Bosulif For Patients With Previously Treated Ph+ CML - RTT News Sep 4th 2012, 20:57 FDA Approves Pfizer's Bosulif For Patients With Previously Treated Ph+ CML RTT News (RTTNews) - Pfizer Inc. (PFE:Quote) announced that the US Food and Drug Administration or FDA has approved Bosulif (bosutinib), an Abl and Src kinase inhibitor, for the treatment of adult patients with chronic, accelerated, or blast phase Philadelphia ... FDA approves Pfizer drug for rare blood cancerBusinessweek FDA approves new orphan drug for chronic myelogenous leukemiaFDA.gov Pfizer wins FDA approval for orphan chronic myelogenous leukemia drugFierceBiotech all 27 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: